William Pierce
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 3
-
- Renal cell carcinoma treatment 5
- Co-authors
- Arie S. Belldegrun (12 shared papers)Robert A. Figlin (13 shared papers)Tomasz M. Beer (1 shared paper)B A Lowe (1 shared paper)W. David Henner (1 shared paper)Jean B. deKernion (8 shared papers)Nancy P. Moldawer (3 shared papers)Faye A. Eggerding (2 shared papers)
- Journals
- Journal of Immunotherapy (3 papers)The Journal of Urology (3 papers)Current Opinion in Oncology (1 paper)Virology (1 paper)Urology (1 paper)
- Partner nations
- United StatesAustriaIsrael
In The Last Decade
William Pierce
16 papers receiving 534 citations
Peers
Comparison fields: 5 of 49
- Oncology 243
- Pulmonary and Respiratory Medicine 266
- Immunology 138
- Cancer Research 62
- Hematology 31
Countries citing papers authored by William Pierce
This map shows the geographic impact of William Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Pierce more than expected).
Fields of papers citing papers by William Pierce
This network shows the impact of papers produced by William Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Pierce. The network helps show where William Pierce may publish in the future.
Co-authors
The 25 scholars most cited alongside William Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 165 | |
| 2 | 1997 | 136 | |
| 3 | 1993 | 55 | |
| 4 | 1986 | 39 | |
| 5 | 1995 | 37 | |
| 6 | Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma. | 1995 | 28 |
| 7 | 1993 | 26 | |
| 8 | 1996 | 22 | |
| 9 | 1994 | 15 | |
| 10 | Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma. | 1993 | 15 |
| 11 | 1994 | 13 | |
| 12 | 1993 | 11 | |
| 13 | 1997 | 9 | |
| 14 | 1983 | 6 | |
| 15 | 1997 | 5 | |
| 16 | 1993 | 2 | |
| 17 | 1993 | 0 |
About William Pierce
William Pierce is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 17 papers that have together received 584 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (5 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Virus-based gene therapy research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (243 citations), Pulmonary and Respiratory Medicine (266 citations), Immunology (138 citations), Cancer Research (62 citations) and Hematology (31 citations). William Pierce has collaborated with scholars based in United States, Austria and Israel. Frequent co-authors include Arie S. Belldegrun, Robert A. Figlin, Tomasz M. Beer, B A Lowe, W. David Henner, Jean B. deKernion, Nancy P. Moldawer, Faye A. Eggerding, Barbara J. Gitlitz and C L Tso. Their work appears in journals such as Journal of Immunotherapy, The Journal of Urology, Current Opinion in Oncology, Virology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.